Category: Digital Therapeutics

Luminopia Announces FDA Approval of Digital Therapeutic to Improve Vision in Children with Amblyopia (Lazy Eye)

Luminopia Announces FDA Approval of Digital Therapeutic (DTx) to Improve Vision in Children with Amblyopia (Lazy Eye)

Xealth Platform - Series B Funding - Digital Health News

Xealth Raises $24 Million Series B Funding to Accelerate Digital Health

Xealth, a leading digital health solutions enabler, has closed its Series B funding with $24 million, advancing digital connections between clinicians and their patients, driving better outcomes. The Xealth digital health platform is currently available to more than 100,000 physicians, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Xealth’s Series B funding round will fuel the growth of the company’s team, approximately doubling its size. It will also support product innovation, including further enhancing its intelligence engine to help better health systems determine which tools are working best with which patients, further enabling the scale of Xealth’s deployment across the US.

Wellinks Announces Initiation of IRB Approved Study of Digital Health Solution for COPD

Wellinks has announced the initiation of an IRB approved research pilot study for patients previously diagnosed with COPD. The study aims to demonstrate the feasibility of collecting and tracking information essential to managing COPD patients, including adherence to medication regimen, lung health, and symptoms onset. Investigators will also assess engagement and satisfaction with the Wellinks solution.